标题:The Association of HMGB1 Expression with Clinicopathological Significance and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis and Literature Review
作者:Zhang, Lu; Han, Jianjun; Wu, Huiyong; Liang, Xiaohong; Zhang, Jianxin; Li, Jian; Xie, Li; Xie, Yinfa; Sheng, Xiugui; Yu, Jinming
作者机构:[Zhang, Lu] Univ Jinan, Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Sch Med & Life Sci,Dept Gynecol Oncol, Jinan, Shandong, Peoples R China.; 更多
通讯作者:Sheng, XG
通讯作者地址:[Sheng, XG]Shandong Canc Hosp & Inst, Dept Gynecol Oncol, Jinan, Shandong, Peoples R China.
来源:PLOS ONE
出版年:2014
卷:9
期:10
DOI:10.1371/journal.pone.0110626
摘要:Background: Hepatocellular carcinoma (HCC) is the fifth most common cancer, and it is the second most common cancer-related mortality globally. The prognostic value of high mobility group box 1 (HMGB1) remains controversial. The purpose of this study is to conduct a meta-analysis and literature review to evaluate the association of HMGB1 expression with the prognosis of patients with HCC.; Methods: A detailed literature search was made in Medline, Google Scholar and others for related research publications. The data were extracted and assessed by two reviewers independently. Analysis of pooled data were performed, Hazard Ratio (HR) and mean difference with corresponding confidence intervals (CIs) were calculated and summarized respectively.; Results: 10 relevant articles were included for this meta-analysis study. HMGB1 mRNA levels in HCC were significantly higher than those in normal (p < 0.00001) and para-tumor tissues (p = 0.002) respectively. The protein levels of HMGB1 in HCC were significantly higher than those in para-tumor tissues (p = 0.005). Two studies reported the serum HMGB1 levels in patients with HCC of TNM stages, and indicating significantly different between stage I and II, stage II and III, as well as stage III and IV (two studies showed p < 0.01 and p < 0.001 respectively). The overall survival (OS) was significantly shorter in HCC patients with high HMGB1 expression compared those with low HMGB1 expression and the pooled HR was 1.31 with 95% CI 1.20-1.44, Z = 5.82, p < 0.0001. Two additional studies showed that there were higher serum HMGB1 levels in patients with chronic hepatitis than those in healthy people (p < 0.05).; Conclusions: The results of this meta-analysis suggest that HMGB1 mRNA and protein tissue levels in the patients with HCC are significantly higher than those in para-tumor and normal liver tissues respectively. Tissue HMGB1 overexpression is a potential biomarker for HCC diagnosis, and it is significantly associated with the prognosis of patients with HCC.
收录类别:SCIE
WOS核心被引频次:3
资源类型:期刊论文
TOP